United States · FDA National Drug Code directory
Cytarabine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61703-155_e3a8c0e9-19ed-49b7-8464-11e8806f47fd
- Product NDC
- 61703-155
- Form
- INJECTION, SOLUTION
- Composition / generic term
- CYTARABINE
- Labeler
- Hospira, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250407
- Source listing expiry
- 20261231
Source-listed ingredients
- CYTARABINE — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-155-01) / 20 mL in 1 VIAL, SINGLE-DOSE · 61703-155-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →